Biofrontera (BFRI) Net Income (2020 - 2025)
Biofrontera's (BFRI) quarterly Net Income came in at $7.9 million in Q4 2025, up 663.9% year-on-year from $1.0 million in Q4 2024, and up 218.39% quarter-over-quarter from -$6.6 million in Q3 2025.
Biofrontera (BFRI) Net Income (2020 - 2025) Analysis & Trends
Biofrontera's Net Income history runs 6 years deep, the most recent figure standing at $7.9 million for Q4 2025.
- On a quarterly basis, Net Income rose 663.9% year-over-year to $7.9 million in Q4 2025; TTM through Dec 2025 was -$8.3 million, a 53.24% increase from a year earlier, with the FY2025 full-year figure at -$8.3 million, up 53.24% from the prior year.
- Net Income climbed to $7.9 million in Q4 2025 per BFRI's latest filing, from -$6.6 million in the prior quarter.
- Across five years, Net Income topped out at $7.9 million in Q4 2025 and bottomed at -$16.0 million in Q3 2021.
- The 5-year median for Net Income is -$3.9 million (2021), against an average of -$4.2 million.
- Across the five-year window, Net Income tumbled 7698.39% in 2021 and surged 663.9% in 2025, its largest moves.
- Year by year, Net Income stood at -$14.5 million in 2021, then soared by 80.8% to -$2.8 million in 2022, then jumped by 226.61% to $3.5 million in 2023, then plunged by 139.59% to -$1.4 million in 2024, then jumped by 663.9% to $7.9 million in 2025.
- Per Business Quant, the three latest BFRI Net Income figures stand at $7.9 million (Q4 2025), -$6.6 million (Q3 2025), and -$5.3 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 7.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.87 Mn |
| Sep 30, 2025 | -6.65 Mn |
| Jun 30, 2025 | -5.32 Mn |
| Mar 31, 2025 | -4.20 Mn |
| Dec 31, 2024 | -1.40 Mn |
| Sep 30, 2024 | -5.67 Mn |
| Jun 30, 2024 | -257,000.00 |
| Mar 31, 2024 | -10.44 Mn |
| Dec 31, 2023 | 3.53 Mn |
| Sep 30, 2023 | -6.34 Mn |
| Jun 30, 2023 | -9.84 Mn |
| Mar 31, 2023 | -7.48 Mn |
| Dec 31, 2022 | -2.79 Mn |
| Sep 30, 2022 | -2.57 Mn |
| Jun 30, 2022 | -850,000.00 |
| Mar 31, 2022 | 5.56 Mn |
| Dec 31, 2021 | -14.51 Mn |
| Sep 30, 2021 | -16.01 Mn |
| Jun 30, 2021 | -3.66 Mn |
| Mar 31, 2021 | -3.53 Mn |